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ABSTRACT 44 
Objective: To compare odds of major depression classification based on the Structured Clinical Interview 45 
for DSM (SCID), the Composite International Diagnostic Interview (CIDI), and the Mini International 46 
Neuropsychiatric Interview (MINI). 47 
Methods: We included and standardized data from three individual participant data meta-analysis (IPDMA) 48 
databases, which included primary studies with depressive symptom scores from the Patient Health 49 
Questionnaire-9, Edinburgh Postnatal Depression Scale, or Hospital Anxiety and Depression Scale – 50 
Depression subscale plus diagnostic interview-based major depression status. For each IPDMA, separately, 51 
we fit binomial generalized linear mixed models to compare adjusted odds ratios (aORs) of (1) major 52 
depression classification, controlling for depression symptom severity and participant characteristics, and 53 
(2) the interaction between interview and symptom severity. Next, we synthesized results using 54 
DerSimonian-Laird random-effects meta-analysis. 55 
Results: In total, 69,405 participants (7,574 [11%] with major depression) from 212 studies were included. 56 
Controlling for symptom severity and participant characteristics, the MINI (74 studies; 25,749 participants) 57 
classified major depression more often than the SCID (108 studies; 21,953 participants; aOR [95% CI] = 58 
1.46 [1.11-1.92]). Classification odds for the CIDI (30 studies; 21,703 participants) and SCID did not differ 59 
overall (aOR [95% CI] =1.19 [0.79, 1.75]), but as screening scores increased, aOR increased less for the 60 
CIDI than the SCID (interaction aOR [95% CI] = 0.64 [0.52-0.80]). 61 
Conclusions: Compared to the SCID, the MINI classified major depression more often. Odds of depression 62 
classification with the CIDI increased less as symptom levels increased. Interpretation of research that uses 63 
diagnostic interviews to classify depression should consider interview characteristics. 64 
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INTRODUCTION 66 
In mental health research, diagnostic interviews are used to classify disorders in a manner consistent 67 
with standard classification systems and replicable across studies [1-4]. There are important differences, 68 
however, in the designs of commonly used interviews. Semi-structured interviews are designed for 69 
administration by trained professionals with diagnostic experience; evaluators can interject queries and use 70 
their clinical judgment to determine whether symptoms are present and significant [1-3]. The Structured 71 
Clinical Interview for DSM (SCID) [4] is the most commonly used semi-structured interview in depression 72 
research [5-7]. Fully structured interviews, in contrast, are designed for lay interviewer administration to 73 
reduce the cost of clinician-administered interviews. They are completely scripted, and evaluators cannot 74 
provide additional explanations or rephrase questions; minimal judgment is involved. They are intended to 75 
maximize reliability but may reduce validity [8]. The Composite International Diagnostic Interview (CIDI) 76 
[8] is the most commonly used fully structured interview for depression research [5-7]. The Mini 77 
International Neuropsychiatric Interview (MINI) [9,10], also common in depression research, is a very brief 78 
fully structured interview, originally described by its developers as a screening interview and intended to be 79 
over-inclusive [10].  80 
Despite their differences, semi-structured interviews, fully structured interviews of conventional 81 
length, and abbreviated alternatives such as the MINI are usually treated as equivalent. For instance, meta-82 
analyses of depression screening tool accuracy typically pool primary study results without consideration of 83 
reference standards [11-17]. Until recently, however, only several small studies, each with 61 depression 84 
cases or fewer, compared classification by different diagnostic interviews [2,18-23]. Recently, three 85 
individual participant data meta-analyses (IPDMA) compared odds of major depression classification 86 
between different diagnostic interviews, controlling for depression symptom severity scores and participant 87 
characteristics [5-7]. Those included an IPDMA with 17,158 participants from 57 primary studies that used 88 
the Patient Health Questionnaire-9 (PHQ-9) to control for depression symptom severity [5], 12,759 women 89 
COMPARISON OF DIAGNOSTIC INTERVIEWS FOR MAJOR DEPRESSION 
 5 
in pregnancy or postpartum from 46 studies that used the Edinburgh Postnatal Depression Scale (EPDS) [6], 90 
and 15,856 participants from 73 studies that used the depression subscale of the Hospital Anxiety and 91 
Depression Scale (HADS-D) [7]. Results suggested that, compared to semi-structured interviews (e.g., 92 
SCID) [4], the CIDI may classify more people with relatively low-level symptoms as depressed but fewer 93 
people with higher symptom levels. The MINI appeared to classify major depression in more people across 94 
the symptom spectrum. There was important imprecision in results, however, including wide confidence 95 
intervals (CIs) around estimates. 96 
Our objective was to synthesize results from three separate IPDMAs datasets to and compare the most 97 
commonly used diagnostic interviews for major depression, the SCID, CIDI, and MINI to determine (1) if 98 
odds ratios for major depression classification using the CIDI and MINI differ from the SCID, controlling 99 
for depression symptom severity and participant characteristics, and (2) if there is an interaction between the 100 
interview and depressive symptom level that would suggest that differences in classification odds are 101 
associated with symptom levels.  102 
MATERIALS AND METHODS 103 
We conducted a two-stage evidence synthesis. We first conducted IPDMAs in the PHQ-9, EPDS, and 104 
HADS datasets, separately, by fitting models with and without interaction terms for depressive symptom 105 
severity in each dataset, separately. Second, we pooled estimates from the results of the three IPDMAs.   106 
Inclusion Criteria for the Included Datasets 107 
For the PHQ-9, EPDS, and HADS-D IPDMAs, datasets from articles in any language were eligible 108 
for inclusion if (1) they included diagnostic classification for current Major Depressive Disorder or Major 109 
Depressive Episode using Diagnostic and Statistical Manual of Mental Disorders [24-27] or International 110 
Classification of Diseases [28] criteria based on a validated semi-structured or fully structured interview; (2) 111 
they included PHQ-9, EPDS, or HADS-D scores; (3) the diagnostic interview and depression screening test 112 
were administered within two weeks of each other; and (4) participants were ≥ 18 years, not recruited from 113 
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youth or college settings, and not recruited from psychiatric settings or because a screening test identified 114 
them as having symptoms of depression [29-31]. For the EPDS, participants were women in pregnancy or 115 
within 12 months postpartum [30]. In each IPDMA, datasets where not all participants were eligible were 116 
included if primary data allowed selection of eligible participants [29-31]. Over 90% of all included studies 117 
in the IPDMA databases used the SCID, CIDI, or MINI diagnostic interviews. Thus, for the present study, 118 
as we did in the published IPDMAs of the EDPS [6] and HADS-D [7], we restricted analyses to studies that 119 
used SCID, CIDI, or MINI.  120 
Search Strategy, Study Selection, Data Acquisition, and Data Extraction 121 
For more details on the search and selection processes, as well as data contribution, extraction, and 122 
synthesis, please see Supplementary Method 1. For information on how the IPDMA datasets and the 123 
analyses conducted in the present study deviated from our previous published IPDMAs on diagnostic 124 
interview performance using the PHQ-9 [5], EPDS [6], and HADS-D [7] IPDMA databases, please see 125 
Supplementary Method 2, Supplementary Method 3, and Supplementary Figure 1. 126 
Statistical Analysis 127 
IPDMAs of PHQ-9, EPDS, and HADS-D Datasets:  128 
We initially standardized symptom severity scores in each dataset. To do this, for each measure, we 129 
converted raw screening tool scores to standardized scores by Z-transformation (subtracting the mean and 130 
dividing by the standard deviation of raw scores). We then meta-analyzed the PHQ-9, EPDS, and HADS 131 
datasets, separately. In each dataset, we fit binomial generalized linear mixed models with a logit link 132 
function to compare the adjusted odds ratio (aOR) of major depression classification for the CIDI versus the 133 
SCID, the MINI versus the SCID, and, as a supplementary analysis, the MINI versus the CIDI, controlling 134 
for depressive symptom levels and other participant characteristics. We adjusted for different covariates in 135 
the models for each dataset, based on relevant measures. For the PHQ-9 and HADS-D datasets, as in the 136 
previously published IPDMAs [5,7], we controlled for depressive symptom severity (continuous 137 
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standardized scores), age, sex, country Human Development Index (very high, high, or low-medium) [32], 138 
and patient care setting (PHQ-9: primary care, outpatient specialty care, inpatient specialty care, non-139 
medical care [33]; HADS-D: outpatient care, inpatient care, non-medical care, mixed inpatient and 140 
outpatient [7]). For the EPDS, we did not control for sex or patient care settings but controlled for 141 
pregnancy versus postpartum status [6]. To account for the correlation between subjects within primary 142 
studies in each dataset, a random intercept was fit. Fixed slopes were estimated for all covariates in each 143 
model. We also fit additional models in each dataset, where we added an interaction term between interview 144 
and depressive symptom severity (continuous PHQ-9, EPDS, and HADS-D standardized scores), to 145 
evaluate whether any differences in aOR of major depression classification were associated with depression 146 
symptom severity.  147 
Synthesis of IPDMA Results: 148 
To synthesize results from the three IPDMAs, we pooled estimates of the aOR for each comparison 149 
(CIDI versus SCID, MINI versus SCID, MINI versus CIDI) and the aOR for the interaction of interview 150 
and depression symptom severity in each comparison, along with 95% CIs. We used DerSimonian-Laird 151 
random effects meta-analysis to pool the aORs [34]. Heterogeneity was examined using the I2 statistic based 152 
on log aORs [35]. Because some studies were included in both the PHQ-9 and HADS-D IPDMAs, as a 153 
sensitivity analysis, we re-analyzed results after removing those studies. 154 
All analyses were conducted in R (R version R 3.5.1 and R Studio version 1.1.463) [36,37] using the 155 
glmer function within the lme4 package [38] and the rma function within the metafor package [39].  156 
RESULTS 157 
In total, 69,405 participants (7,574 [11%] with major depression) were included in the three individual 158 
IPDMAs (Table 1). Of the 212 included primary studies, the SCID was used in 108 studies (21,953 159 
participants, 14% major depression), the CIDI in 30 studies (21,703 participants, 7% major depression), and 160 
the MINI in 74 studies (25,749 participants, 12% major depression). Mean (standard deviation) of raw 161 
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screening tool scores, prior to standardization, were 4.99 (5.26) for the PHQ-9, 6.98 (5.58) for the EPDS, 162 
and 5.16 (4.07) for the HADS-D. Characteristics of individual primary studies are available in 163 
Supplementary Table 1 with details for PHQ-9 update in Supplementary Method 1. There were 13 studies 164 
that were included in both the PHQ-9 and HADS-D datasets, including 2,383 (6%) participants in the PHQ-165 
9 IPDMA and 2,349 participants (15%) in the HADS-D IPDMA. There was no overlap between the EPDS 166 
and the PHQ-9 or HADS-D IPDMAs.  167 
Estimates of aORs of major depression classification by diagnostic interview, controlling for 168 
depressive symptom severity and other participant characteristics, individually and pooled, are reported in 169 
Table 2. Overall odds of major depression classification did not differ for the CIDI versus the SCID (aOR 170 
1.19, 95% CI = 0.79 to 1.75) in the full model that included the interaction term, but there was a significant 171 
interaction between the CIDI and depressive symptom severity; as screening tool scores increased, odds of 172 
major depression classification increased less for the CIDI than for the SCID (interaction aOR = 0.64, 95% 173 
CI = 0.52 to 0.80). As shown in Figure 1, participants with lower depressive symptom severity were more 174 
likely to be classified with major depression with the CIDI compared to the SCID, but the opposite was true 175 
with greater symptom severity. Compared to the SCID, the MINI classified major depression more often 176 
(aOR 1.45; 95% CI = 1.08 to 1.93), controlling for depressive symptom severity and participant 177 
characteristics. There was no apparent interaction between symptom levels and odds of classification 178 
(interaction aOR = 0.95, 95% CI = 0.78 to 1.15). See Figure 2.  179 
Trends of the probability of major depression classification by reference standards for individual 180 
IPDMAs are presented in Supplementary Figures 2-4. There was minimal between-IPDMA heterogeneity in 181 
overall aORs for the comparison of the CIDI versus the SCID and the MINI versus the SCID in models 182 
without the interaction term (I2 = 11% and 0%, respectively) and including the interaction term (I2 = 0% and 183 
0%, respectively). However, there was substantial between-IPDMA heterogeneity of interaction aORs for 184 
both comparisons (I2 = 82% and 82%). See Table 2. 185 
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In the comparison of the MINI versus the CIDI, the MINI was more likely to classify participants as 186 
having major depression than the CIDI (aOR = 2.05; 95% CI = 1.36 to 2.10), controlling for depressive 187 
symptom levels and other participant characteristics. As screening tool scores increased, the odds of major 188 
depression classification increased more for the MINI than for the CIDI (interaction aOR = 1.48, 95% CI = 189 
1.36 to 1.60). Heterogeneity was low for aORs with and without the interaction term, and interaction aORs 190 
(I2 = 0%, 0%, and 0%).  191 
In the individual IPDMAs, some results from the EPDS dataset appeared to diverge from those 192 
generated in the PHQ-9 and HADS-D datasets. However, the number of studies and cases included in the 193 
EPDS dataset for the CIDI and MINI were smaller than any other combination of screening tool and 194 
diagnostic interview. See Table 1. 195 
As a sensitivity analysis, we removed the 13 datasets that were included in both the PHQ-9 and 196 
HADS-D IPDMAs and re-ran all analyses. Results were similar (see Supplementary Table 2).  197 
DISCUSSION 198 
There were two main findings. First, overall odds of major depression classification did not differ 199 
between the fully structured CIDI and the semi-structured SCID. However, adjusting for depressive 200 
symptom levels and participant characteristics, odds of major depression classification with the CIDI 201 
increased significantly less than for the SCID as depressive symptom levels increased. This suggests that, 202 
compared to the SCID, the CIDI is relatively more likely to classify individuals with subthreshold or mild 203 
depressive symptoms and relatively less likely to classify people with more severe symptoms. Second, 204 
participants evaluated with the MINI were significantly more likely to be classified as having major 205 
depression compared to those assessed with the SCID, independent of symptom severity. Between-study 206 
heterogeneity was low for models without the interaction term, but higher for models with interaction terms. 207 
Estimates from the EPDS IPDMA appeared to diverge somewhat from the PHQ-9 and HADS-D IPDMAs. 208 
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This may have been related to the small numbers of studies and major depression cases for the CIDI and 209 
MINI among studies that used the EPDS.  210 
Our findings appear to be consistent with characteristics of the different types of diagnostic 211 
interviews. The MINI was designed as a screening interview and described by its developers as over-212 
inclusive in classifying psychiatric disorders [10]. For the CIDI, the lack of sensitivity to different levels of 213 
depressive symptoms severity may be because the CIDI assesses symptoms in the last 12 months and over 214 
the lifetime, then probes to determine if those symptoms are currently present using only a single question. 215 
In contrast, the SCID and the MINI specifically assess symptoms in the past two weeks. In addition, the 216 
CIDI is much more complicated than the MINI or the SCID. It includes complex branches and is scored 217 
using algorithms subject to calibration, which may influence how well diagnoses map onto DSM criteria. 218 
This could lead to error at all symptom levels, which would result in more people classified at lower 219 
symptom severity levels and fewer at higher levels. 220 
Results were generally consistent with limited evidence from small studies that previously directly 221 
compared depression classification by administering semi- and fully structured diagnostic interviews to the 222 
same participants. In two studies that examined general population samples with low prevalence, fully 223 
structured interviews classified major depression substantially more frequently than semi-structured 224 
interviews [2,20]. On the other hand, in a study of participants in inpatient alcohol treatment, where 225 
symptom severity would be expected to be higher, depression classification likelihood was similar with 226 
semi-structured and fully structured interviews [22].  227 
Our findings have important implications for research, including clinical trials, prognostic and risk 228 
factor studies, diagnostic accuracy studies, and prevalence studies. Concerns have been raised about the 229 
degree to which antidepressant trials are generalizable to real-world clinical practice [40]. Based on our 230 
findings, the method used to classify depression status is also an important consideration. If used to 231 
determine trial eligibility, the CIDI may not identify some participants who would be eligible based on the 232 
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SCID, whereas both CIDI and MINI may include some participants who would not be eligible based on the 233 
SCID, which could reduce the ability to detect treatment effects and further limit applicability to 234 
participants in practice who meet diagnostic criteria. Differences in classifying participants could similarly 235 
reduce the ability to identify potential associations between risk factors and depression. In diagnostic test 236 
accuracy studies, depression screening tool accuracy has been shown to differ across reference standards 237 
[33,41,42]. In studies of major depression prevalence, the MINI will overestimate compared to the SCID, 238 
whereas with the CIDI, relative prevalence will depend on the underlying distribution of depressive 239 
symptoms.  240 
Our findings, which are contrary to the common belief that different reference standards can be 241 
treated equivalently in mental health research, provide evidence that different approaches are needed [43]. 242 
Ideally, researchers would use semi-structured interviews, such as the SCID, which are designed to replicate 243 
diagnostic procedures as closely as possible, to establish diagnostic status. However, this is not always 244 
feasible due to the resources required, including highly trained staff. Future studies are needed to develop 245 
models to calibrate weights of major depression classification based on different reference standards that 246 
could facilitate synthesis of results using different diagnostic interviews. Meanwhile, in selecting a 247 
diagnostic interview for use in research, investigators should consider advantages and disadvantages of 248 
different interviews, including performance characteristics and resources required. In published studies, 249 
authors should comment on potential implications of the type of diagnostic interview that was used. Users 250 
of research, including clinicians, should be aware that results from studies that use the CIDI or MINI may 251 
differ from what would be found using semi-structured interviews, which are designed to replicate 252 
diagnostic procedures as closely as possible. It is also important to underline that from a clinimetric 253 
perspective [44-46], assessment of diagnostic status alone is not sufficient, but that rating tools and self-254 
report questionnaires are needed to characterize symptom severity and the specific nature of experienced 255 
symptoms. 256 
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A strength of the present study was the inclusion of 69,405 participants with 7,574 (11%) major 257 
depression cases from 212 studies. This allowed us to overcome limitations of previous IPDMAs and 258 
generate more precise estimates. A second strength was that data within each included dataset were 259 
standardized in terms of definitions of major depression classification, eligibility criteria, and variables. A 260 
limitation to consider is that for included IPDMAs, we could not obtain primary data for 28 of 117 eligible 261 
PHQ-9 studies (24% of eligible studies, 17% of eligible participants), 19 of 64 EPDS studies (30% of 262 
eligible studies, 30% of eligible participants), and 47 of 116 HADS-D studies (41% of eligible studies, 29% 263 
of eligible participants). A second is that we used standardized scores instead of raw depression symptom 264 
scores, which required making the assumption that a standard deviation change in scores was equivalent 265 
across different screening tools. Third, because only three estimates were pooled, our ability to estimate 266 
heterogeneity and explore possible causes was limited. Fourth, some studies were included in both the 267 
PHQ-9 and HADS-D IPDMAs. However, a sensitivity analysis showed that results were similar when these 268 
studies were removed. Fifth, we examined the SCID, CIDI, and MINI, because we did not have access to 269 
enough studies to include other diagnostic interviews. It is unclear to what degree our findings would 270 
generalize to other diagnostic interviews. Finally, our study did not include a head-to-head comparison of 271 
interviews from a randomized controlled trial or by administering different interviews to all participants. It 272 
is unlikely, however, that such as study would be feasible with a large enough sample to draw conclusions 273 
with confidence. Our study design, despite its limitations, overcame this barrier. 274 
To conclude, the semi-structured SCID was designed to replicate diagnostic standards and procedures 275 
as closely as possible. By synthesizing results from three large IPDMAs, we found that the most commonly 276 
used fully structured diagnostic interviews to classify major depression, the CIDI and MINI, did not 277 
perform equivalently to the SCID. The CIDI is not as responsive as the SCID to different levels of reported 278 
depressive symptoms, and the MINI identifies more cases across the spectrum of depressive symptom 279 
levels. Researchers should carefully consider the advantages and disadvantages of using these diagnostic 280 
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interviews, and findings from studies based on the CIDI or the MINI should be interpreted considering how 281 
their performance deviates from that of the SCID. 282 
  283 
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Rochester, New York, USA; Humberto Correa, Faculty of Medicine, Universidade Federal de Minas 372 
Gerais. Belo Horizonte, MG, Brazil; Tiago Castro e Couto, Federal University of Uberlândia, Brazil; Daniel 373 
Cukor, Rogosin Institute, New York, New York, USA; Eli Dabscheck, The Alfred Hospital, Prahran, VIC, 374 
Australia; Federico M. Daray, Institute of Pharmacology, School of Medicine, University of Buenos Aires, 375 
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Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa; Barbara 390 
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FIGURE LEGENDS 701 
 702 
Figure 1. Comparison of major depression classification odds of the Composite International Diagnostic 703 
Interview (CIDI) versus the Structured Clinical Interview for DSM (SCID) 704 
 705 
The figure presents the aOR of major depression classification for the CIDI compared to the SCID for 706 
primary studies based on the PHQ-9, EPDS, and HADS-D and pooled estimates at standardized scores of -707 
1, 0, 1, 2 and 3. The standardized scores of -1, 0, 1, 2 and 3 are approximately equal to scores of 0, 5, 10, 16 708 
and 21 on the PHQ-9 (SD = 5.26); 1, 7, 13, 18 and 24 on the EPDS (SD = 5.58); and 1, 5, 9, 13 and 17 on 709 
the HADS-D (SD = 4.07). We present standardized scores from -1 to 3, because raw scores corresponding 710 
to standardized scores below -1 or above 3 would be negative or beyond the maximum scores of the 711 
included screening tools. 712 
 713 
Abbreviations: EPDS: Edinburgh Postnatal Depression Scale; HADS-D: Depression subscale of Hospital 714 
Anxiety and Depression Scale; META: Pooled estimates from the synthesis meta-analysis. PHQ-9: Patient 715 
Health Questionnaire-9.  716 
 717 
  718 
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Figure 2. Comparison of major depression classification odds of the Mini International Neuropsychiatric 719 
Interview (MINI) vs. the SCID considering the interaction between depressive symptom severity and the 720 
MINI 721 
 722 
The figure presents the aOR of major depression classification for the MINI compared to the SCID for 723 
primary studies based on the PHQ-9, EPDS, and HADS-D and pooled estimates at standardized scores of -724 
1, 0, 1, 2 and 3. The standardized scores of -1, 0, 1, 2 and 3 are approximately equal to scores of 0, 5, 10, 16 725 
and 21 on the PHQ-9 (SD = 5.26); 1, 7, 13, 18 and 24 on the EPDS (SD = 5.58); and 1, 5, 9, 13 and 17 on 726 
the HADS-D (SD = 4.07). We present standardized scores from -1 to 3, because raw scores corresponding 727 
to standardized scores below -1 or above 3 would be negative or beyond the maximum scores of the 728 
included screening tools. 729 
 730 
Abbreviations: EPDS: Edinburgh Postnatal Depression Scale; HADS-D: Depression subscale of Hospital 731 
Anxiety and Depression Scale; META: Pooled estimates from the synthesis meta-analysis. PHQ-9: Patient 732 
Health Questionnaire-9.  733 
 734 
